1.) Type in Drug Name Type in your drug name, select it from the search suggestion drop-down list and then hit enter. The Related Drug Information Index provides comprehensive access to all drug information related to a specific drug Types of content include full prescribing information, drug summaries, Full Prescribing Information Continuing Medication Education (Full PI CME), Medication Guides, Risk Evaluation and Mitigation Strategies (REMS Summaries), REMS. Advair works best for me—how can I save until there is a generic alternative? Use a manufacturer discount (co-pay card). GlaxoSmithKline, Advair’s manufacturer, offers a discount that can reduce your cost to as low as $10 per inhaler—if you have insurance. and it occurred in a facility outside a doctor's office, that facility may be legally required to report to FDA and/or the manufacturer. Please notify the person in that facility Advair is a prescription drug containing fluticasone and salmeterol that helps asthma sufferers control asthma attacks. Advair comes in an easy-to-operate disc-shaped inhaler called the Diskus. Advair Diskus inhalation is a steroid and bronchodilator combination medicine that is used to prevent asthma attacks. It is also used to prevent flare-ups or worsening of chronic obstructive pulmonary disease associated with chronic bronchitis and/or emphysema. Some reactions to Advair, such as depression, can be quite serious. This eMedTV Web page provides detailed lists of possible side effects that should be reported to your healthcare provider, including some that might not even be related to the drug. What other drugs will affect Advair? Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective. The combination of fluticasone and salmeterol (Advair Diskus, Advair HFA) is used to treat difficulty breathing, wheezing, shortness of breath, coughing, and chest tightness caused by asthma. Mylan has finally muscled its generic of GlaxoSmithKline’s respiratory blockbuster Advair onto the US market, after a catalogue of delays. The FDA approved Mylan’s version of the asthma and chronic obstructive pulmonary disease (COPD) brand yesterday, putting around $1bn in Advair sales at risk of steep decline.